Presentation at the FDA’s Stakeholder Meeting on the Reauthorization of MDUFA
View complete testimony as PDF
In its presentation at the Food and Drug Administration’s (FDA’s) stakeholder public meeting to discuss proposed recommendations for the reauthorization of the Medical Device User Fee Amendments (MDUFA) for fiscal years 2023 through 2027, Public Citizen offers several specific recommendations for strengthening the agency’s oversight of high-risk medical devices to better protect patients from unsafe or ineffective products.
See Public Citizen’s other work regarding the medical device review process.